1. Introduction {#s0005}
===============

The application of Genome-Scale Metabolic Models (GEMs) to the design and optimization of microbial strains is of great biotechnological value and has been the topic of extensive research ([@bib22], [@bib43]). The interest in this topic has fuelled the development of numerous computational methods that can simulate the fluxes within GEMs and search for combinations of genetic modifications that optimize a desirable phenotypical trait ([@bib30], [@bib37], [@bib66]). These strain engineering methods have been applied to the optimization of the production of a range of different chemicals, which resulted in the construction of microbial strains with improved phenotypes ([@bib2], [@bib7], [@bib9], [@bib13], [@bib21], [@bib54]).

Although the performance of *in silico* "inspired" strains is better than the wild-type, the experimental production yields are often below the simulated values. One of the factors that can affect the quantitative reproducibility of the results obtained with strain engineering algorithms is the quality of the GEM. If a GEM does not represent the full extent of the metabolic activities of the host organism or contains errors, it might lead to inconsistencies between simulations and *in vivo* data.

GEMs are normally validated by testing their predictions of core physiological parameters, such as the maximum growth yield under different environmental conditions or the set of essential genes in a particular condition ([@bib17], [@bib18], [@bib45]). The validation process rarely includes the analysis of the intracellular fluxes, even for models of well-studied organisms, such as *Escherichia coli* and *Saccharomyces cerevisiae* ([@bib17], [@bib18], [@bib20], [@bib45]). One of the possible reasons for the lack of validation of GEMs at the flux level might be the existence of multiple objective functions to simulate flux distributions, which can yield different results for the same model and result in a subjective quality assessment.

The accuracy of the fluxes simulated with GEMs is of special relevance when the simulation algorithms used for computing mutant phenotypes require a reference (wild-type) flux distribution*,* such as MOMA ([@bib62]), lMOMA ([@bib5]), ROOM ([@bib63]) or MiMBL ([@bib8]). Given the absence of flux data at the genome scale, the reference flux distribution used by the algorithms stated above is usually calculated using Flux Balance Analysis (FBA; [@bib51]) or parsimonious Flux Balance Analysis (pFBA; [@bib36]) ([@bib1], [@bib29], [@bib56]). Consequently, given the lack of validation of GEMs at the flux prediction level, the reference flux distributions calculated using FBA/pFBA can contain flux values that are not consistent with *in vivo* values, which may compromise the subsequent phenotype simulations. The sensitivity of phenotype simulations towards the reference fluxes has been demonstrated before for the MOMA algorithm ([@bib62]), showing that even small deviations in the wild-type flux distribution can have an impact on the simulation outcome. Furthermore, [@bib8] also noted that the reference flux distribution had a significant impact when MiMBL was used to simulate single gene deletion mutants. Therefore, it is of special interest to analyse the validity of flux distributions calculated with commonly used methods, such as FBA/pFBA, in order to prevent inaccurate reference flux distributions from affecting negatively the phenotypical predictions for mutant organisms.

Besides the accuracy of the reference flux distribution, there are also other ways of improving the results of phenotype simulation algorithms. For example, there is a group of simulation methods that uses gene expression data to improve the simulation accuracy ([@bib38]). Methods such as RELATCH ([@bib31]) can analyse the changes in gene expression between the wild-type and the mutant strain to infer about the direction and magnitude of flux changes expected. However, these methods require gene expression data, for both the wild-type and mutant organism, which reduces their application to the simulation of strains that are already constructed and characterized at the transcriptomic level.

[Fig. 1](#f0005){ref-type="fig"} summarizes the steps required to perform simulations of mutant phenotypes using algorithms that require a reference set of fluxes. As mentioned above, GEMs are usually not validated at the flux level and not much is known about the accuracy of the reference flux distributions obtained with FBA/pFBA. Therefore, we propose that additional steps should be included in the *in silico* strain engineering framework in order to verify the accuracy of the flux distributions used by the simulation algorithms. When the fluxes obtained are not consistent with the knowledge available for a particular organism, further curation and validation of the model should be performed.Fig. 1Contextualization of the work described here within the workflow of *in silico* strain design. Cited algorithms: MOMA ([@bib62]), LMOMA ([@bib5]), OptGene ([@bib57]), BiMOMA ([@bib32]).Fig. 1

*S. cerevisiae* is one of the most studied microorganisms and a considerable amount of information about its metabolism is available. It has proven to be quite versatile in terms of industrial applications, making it very attractive for metabolic engineering. Several GEMs have been published for *S. cerevisiae* over the last ten years ([@bib15], [@bib20], [@bib27], [@bib34], [@bib45], [@bib49], [@bib52]) and their predictions of maximum growth yield and exchange fluxes using FBA is generally quite good. These facts make *S. cerevisiae* very attractive for investigating in detail the capacity of GEMs and simulation methods to predict the intracellular flux distribution of the central carbon metabolism.

Here we analysed the flux distributions simulated with pFBA for a selection of *S. cerevisiae* GEMs and verified that there are considerable differences in the predicted fluxes among the models tested. The underlying causes for the differences observed were traced back to the production and consumption of NADPH/NADH, which led us to perform a detailed analysis and curation of all reaction involved in the metabolism of these cofactors. Additionally, we also investigated the impact of using different flux distributions on the simulation of mutant phenotypes. The production of two organic acids was used as case-study to validate if the improved flux distributions affected the prediction of the simulation algorithm. Overall, the improvements made to the metabolism of NADPH resulted in phenotype simulations more consistent with physiological data available in the literature, which supports the assumption that *in silico* strain design could benefit from additional validation steps as here proposed.

2. Methods {#s0010}
==========

2.1. Model retrieval and pre-processing {#s0015}
---------------------------------------

The models *i*FF708 ([@bib20]) and *i*TO977 ([@bib52]) were obtained in SBML format from the authors\' website ([http://biomet-toolbox.org/index.php? page=models-S.cerevisiae](http://biomet-toolbox.org/index.php?page=models-S.cerevisiae){#ir0005}). The model *i*MM904 ([@bib45]) was downloaded and converted to SBML using the script provided by the authors in the supplementary material. Yeast 6.06 ([@bib26]) was downloaded in SBML format from the project\'s website: <http://sourceforge.net/projects/yeast/files/>.

Each model was imported into OptFlux 3.07 ([@bib58]) and the *in silico* environmental conditions were set to mimic minimal growth media supplemented with glucose under fully-aerobic conditions (ammonia: unconstrained uptake, phosphate: unconstrained uptake, sulfate: unconstrained uptake, oxygen: unconstrained uptake, glucose: fixed uptake of 1.15 mmol/gCDW h).

2.2. Flux simulations {#s0020}
---------------------

All simulations were executed within OptFlux 3.07 using IBM ILOG CPLEX optimization studio (academic) as the linear programming solver. The simulation method chosen to compute the flux distributions was pFBA ([@bib36]) and the objective function was defined as the maximization of the biomass production.

In order to compare experimental flux data with the simulations it was necessary to create an equivalence map between the main metabolic reactions present in central carbon metabolism and the reactions of the models. Each model was inspected manually to determine which reaction (or reactions) corresponds to an enzymatic activity from the central metabolism. In genome-scale metabolic models it is common to find duplicated reactions and other stoichiometrically equivalent pathways that catalyse the same chemical transformation. The phosphorylation of glucose, for example, can be carried by hexokinases or glucokinases. To simplify the visualization of the fluxes through the central metabolism of *S. cerevisiae,* the fluxes through equivalent reactions were summed into a single value. Using the example above, all the reactions phosphorylating glucose to glucose-6-phosphate present in each model were treated as a single entity. The equivalence map for each of the models tested is provided in supplementary [tables S6 and S7](#s0070){ref-type="fn"}.

2.3. Flux variability analysis {#s0025}
------------------------------

To verify the uniqueness of the flux distributions calculated by FBA, each reaction\'s variability was tested by flux variability analysis ([@bib10], [@bib39]). Briefly, the value of the objective function (biomass growth) was fixed at its maximum and each target flux was then minimized or maximized. However, since the models tested here contained many reactions in the central metabolism that are duplicated, when one of them is minimized the flux could be routed through the other. Furthermore, if the duplicated reactions are reversible, futile cycles can arise. To avoid these irrelevant glitches in the analysis, when one reaction\'s variability was tested, all the other "equivalent partners" were disabled.

2.4. Optimizations of metabolic engineering targets {#s0030}
---------------------------------------------------

In order to search for strain designs with improved production of acetate or mevalonate, the evolutionary optimization algorithms included in OptFlux were used ([@bib57], [@bib59]). The method selected to simulate the mutant phenotypes was the linear version ([@bib5]) of the MOMA algorithm ([@bib62]), where the Euclidian distance of the fluxes is replaced by the Manhattan distance. Two different phenotype objective functions were optimized by the evolutionary algorithm: the Biomass Product Coupled Yield (BPCY; [@bib57]) or the maximization of the target flux assuming a minimum biomass growth threshold (YIELD). The evolutionary algorithm was run at least three times for each target, setting the number of solution evaluations to 50,000 and the maximum number of knock-outs allowed to 5. In order to reduce the total number of possible knock-out targets, the set of essential reactions and dead-end reactions was not considered in the optimizations.

3. Results and discussion {#s0035}
=========================

3.1. Comparison of genome-scale metabolic models {#s0040}
------------------------------------------------

Since the first GEM of *S. cerevisiae* was published in 2003 ([@bib20]), several authors have expanded and improved the metabolic reconstruction of this microorganism (reviewed by [@bib50], [@bib53]). [Table 1](#t0005){ref-type="table"} shows the details for a selection of the GEMs available in the literature for *S. cerevisiae*, focusing on model size and other relevant parameters. The analysis of [Table 1](#t0005){ref-type="table"} reveals that over the years additional ORFs and metabolic reactions were progressively included in the models, which resulted in models of increasing size. In comparison to *i*FF708, the newer models include additional compartments and some of them were balanced at the elemental level.Table 1Details of selected GEMs available for *S. cerevisiae*.Table 1**ModelYearORFs includedReactions includedOther information***i*FF708 ([@bib20])200370811753 compartments (2 metabolic[a](#tblt0005-fn1){ref-type="table-fn"})*i*ND750 ([@bib15])200475014898 compartments (7 metabolic), Elementally balanced*i*LL672 ([@bib34])200567210383 compartments (2 metabolic)*i*IN800 ([@bib49])200880014463 compartments (2 metabolic)*i*MM904 ([@bib45])200990414128 compartments (7 metabolic), Elementally balanced*i*TO977 ([@bib52])201397715664 compartments (3 metabolic)Yeast 6 ([@bib26])2013900188815 compartments (7 metabolic), Elementally balanced[^1]

The validation of a GEM is usually performed using large-scale gene essentiality data and/or extracellular flux predictions (reviewed by [@bib60]). Since the capability of these models to predict the intracellular flux distributions is rarely analysed, it is hard to select the most suitable model for applications that require the computation of a reference set of fluxes (such as MOMA, ROOM, etc.). In order to clarify the suitability of the GEMs of *S. cerevisiae* to predict the internal flux distribution of this microorganism, we selected four different models from [Table 1](#t0005){ref-type="table"} (*i*FF708, *i*MM904, *i*TO977 and Yeast 6) and used them for simulations with pFBA under the same environmental conditions. *i*FF708 was chosen for this analysis because it is still widely used for phenotype simulation purposes ([@bib2], [@bib7], [@bib9], [@bib54]), and the three other models were chosen as they are the three most recent ones ([Table 1](#t0005){ref-type="table"}). The flux values were taken from a pFBA simulation and normalized to a glucose uptake rate of 100 arbitrary units.

When the models selected for analysis were simulated under the same conditions it was noticeable that Yeast 6 was predicting a maximum specific growth rate considerably higher than the others (0.16 h^−1^ vs. 0.11 h^−1^). A detailed analysis of this problem revealed that an unreasonably high flux through the ATP synthase was generating ATP without a corresponding input of NADH in the oxidative phosphorylation pathway. This odd behaviour was caused by a cycle of proton export from the mitochondria, originating from the aspartate:proton symporter (reaction r_1117 in the model). By using a series of transporters and metabolic reactions, Yeast 6 was capable of creating a proton gradient across the mitochondrial membrane without any energy input. The solution to this problem was to disable the activity of the aspartate:proton symporter in the direction from the mitochondria to the cytosol. Since under aerobic conditions there is a proton gradient across the mitochondria membrane, the transport of aspartate is more likely to occur in the direction of this gradient, i.e., from the cytosol to the mitochondria. This issue allowed the ATP synthase to be active even in the absence of oxygen, which can also explain why it is necessary to manually disable this enzyme to obtain valid anaerobic simulations with this model ([@bib26]). The problem with the unconstrained transport of protons from the mitochondria to the cytosol in the model Yeast 6 has been patched in the most recent version of the Yeast consensus model (see revision 7.11 in <http://yeast.sourceforge.net/>).

Using the amended Yeast 6 and the other models the flux distributions were computed and represented in a metabolic map of the central metabolic pathways as shown in [Fig. 2](#f0010){ref-type="fig"}. One of the most noticeable differences observed is the absence of flux in the oxidative Pentose Phosphate Pathway (PPP) in the most recent models (*i*MM904, *i*TO977 and Yeast 6) in comparison to *i*FF708. An analysis of the fluxes revealed that in iTO977 and *i*MM904 all the NADPH required for anabolic processes originated from the cytosolic NADP-specific isocitrate dehydrogenase, which is inconsistent with the role of the PPP in the production of this cofactor (it is estimated that 26--44% of the total glucose that is consumed enters the PPP \[[@bib23], [@bib28]\]). Regarding the Yeast 6 model, we observed that the main reaction fixing ammonia was the NADH-dependent glutamate dehydrogenase instead of the NADPH dependent variant (flux not shown). Furthermore, in Yeast 6, the NADPH required for most anabolic processes was being produced by the cytosolic aldehyde dehydrogenase and the cytosolic C1-tetrahydrofolate synthase.Fig. 2Distribution of fluxes in the central metabolism predicted by pFBA for the models: *i*FF708 (green), *i*MM904 (blue), *i*TO977 (orange) and Yeast 6 (black). The flux values shown are normalized to a glucose uptake rate of 100 arbitrary units. Growth rates for each model: *i*FF708--0.11 h^−1^, *i*MM904--0.11 h^−1^, *i*TO977--0.11 h^−1^, Yeast 6--0.09 h^−1^. Reactions: ACONT- aconitase, ACS- acetyl-CoA *syn*thetase, ADH- alcohol dehydrogenase, AKGD- alpha-ketoglutarate dehydrogenase, ALD- aldehyde dehydrogenase, CSm- citrate synthase, FBA- fructose 1,6-bisphosphate aldolase, FUM- fumarase, G3PD1ir- glycerol-3-phosphate dehydrogenase, G3PT- glycerol-1-phosphatase, GAPD- glyceraldehyde-3-phosphate dehydrogenase, GHMT2r- serine hydroxymethyltransferase, GND- 6-phosphogluconate dehydrogenase, HEX- hexokinase, ICD- mitochondrial isocitrate dehydrogenase, MDH- mitochondrial malate dehydrogenase, ME- mitochondrial malic enzyme, PDC- pyruvate decarboxylase, PDH- pyruvate dehydrogenase, PFK- phosphofructokinase, PGI- phosphoglucose isomerase, PGK- 3-phosphoglycerate kinase, PGMT- phosphoglucomutase, PP3- sum of the non-oxidative reactions of the pentose phosphate pathway producing glyceraldehyde-3-phosphate, PP6- sum of the non-oxidative reactions of the pentose phosphate pathway producing fructose-6-phosphate, PSP- phosphoserine phosphatase, PYC- pyruvate carboxylase, PYK- pyruvate kinase, SUCD- succinate dehydrogenase, SUCOAS- succinyl-CoA ligase, THRS- threonine synthase, TPI- triose phosphate isomerase. Metabolites: 13dPG- 1,3-diphosphoglycerate, 3PG- 3-phosphoglycerate, AcCoA- acetyl-CoA, Akg- 2-oxoglutarate, Cit- citrate, DHAP- dihydroxyacetone-phosphate, Fum- fumarate, G3P- glyceraldehyde-3-phosphate, Icit- isocitrate, Mal - L-malate, Oaa- oxaloacetate, Ser- L-serine, Succ- succinate, SucCoa- succinyl-CoA.(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 2

The model comparison shown in [Fig. 2](#f0010){ref-type="fig"} indicates that among the tested models *i*FF708 shows the distribution of fluxes most consistent with flux distributions of *S. cerevisiae* in glucose limited chemostats ([@bib23], [@bib28]). In comparison to *i*FF708, the remaining models performed worst mostly in the fluxes related to NADPH metabolism. Therefore, in order to improve the flux accuracy of the most recent *S. cerevisiae* GEMs it seems imperative to curate the areas of the metabolism involved in NADPH production and consumption.

3.2. Model curation based on cofactor utilization {#s0045}
-------------------------------------------------

Given all the indications pointing towards problems with the metabolism of NADPH in the models of *S. cerevisiae* under analysis, all the metabolic reactions involving this cofactor were collected and their feasibility was examined. Since NADH can replace NADPH as the electron donor in many reactions of *S. cerevisiae*, the reactions where NADH was present were also included in the list of reactions to be curated.

The curation process started by analysing one of the major issues detected in the course of the model comparison, which was the production of NADPH by the cytosolic isocitrate dehydrogenase in the models *i*MM904 and *i*TO977. The gene coding for the cytosolic isocitrate dehydrogenase (*IDP2*) is known to be repressed by glucose ([@bib25]), but in glucose-limited conditions, its activity might still be present. Therefore, one cannot rule out the contribution of this gene to the overall NADPH production based on regulatory phenomena alone. The work of [@bib61] has shown that the NADPH/NADP^+^ ratio can also act as an inhibition factor for the cytosolic isocitrate dehydrogenase. In the same publication, [@bib61] reported that under growth on glucose the NADPH/NADP^+^ ratio is high enough to inhibit the cytosolic isocitrate dehydrogenase of *S. cerevisiae*. In addition to this inhibitory effect, it is also relevant to point out that the concentration of NADPH/NADP^+^ can also affect the change in Gibbs free energy of this reaction, which should favour the equilibrium in the direction of NADPH consumption.

Assuming that the findings of [@bib61] can be generalized to other enzymes that use NADPH or NADH as cofactors we curated manually all cytosolic reactions containing either of these cofactors in the models under analysis. Since under fully-aerobic glucose-limited conditions the ratio of NADPH/NADP^+^ is usually high, in order to drive anabolic reactions, and the ratio of NADH/NAD^+^ is usually low, in order to promote fast metabolic oxidation of the substrate ([@bib11], [@bib14], [@bib61], [@bib65]), the reversibility of cytosolic reactions should favour the consumption of NADPH and the production of NADH. Therefore, most of the reactions present in each model were constrained in the direction of NADPH consumption and NADH production to enforce cofactor availability constraints. The curation process is documented in the supplementary [Tables S1--S4](#s0070){ref-type="fn"} and the final list of constrained reactions is shown in [Table 2](#t0010){ref-type="table"}. The constraints from [Table 2](#t0010){ref-type="table"} are not intended to be used as general revisions of the models tested here, but rather as condition specific flux bounds. Since the cofactor abundance assumed in the curation process might not be valid for other cultivation conditions, the flux constraints should be used exclusively for simulating wild-type *S. cerevisiae* in glucose limited fully oxidative conditions.Table 2List of changes in the flux bounds applied during the curation process for each model (reactions are identified by their IDs on the model). The reversibility constrained category includes all reversible reactions that were made irreversible to impose cofactor availability constraints and the inactivated category includes all irreversible reactions that were inactivated to impose cofactor availability constraints.Table 2**ModelReversibility constrainedInactivatedNADHNADPHNADHNADPH*****i*****FF708**MDH3, MDH2, ADH2, ADH1, ADH5, ADH4, BIO2, SFA1_2, SFA1_1, LYS1, TDH1, TDH2, TDH3HMG2, HMG1, ECM17, MET10, LYS9U45\_, PRO3_3, FAS1_4, FOX2, PRO2_1, LYS2_2, HOM6_1TYR1, IDP3_1, ARA1_2, ALD6, IDP2_1***i*****MM904**BTDD-RR, FALDH, 2HBO, ALCD2x, SACCD2, MDH, GAPDHMGCOAR, SACCD1, SULRAASAD2, G5SD2, HPROa, ALCD25xi, ALCD2ir, ALCD26xi, ALCD22xi, FMNRx, ALCD23xi, C22STDSx, LNS14DMx, HSDxi, ALCD24xiLSERDHr, ATHRDHr, PPND2, GLYCDy, ARAB1D2, ICDHy, ALDD20y, ALDD2y***i*****TO977**BIO2, LYS1, r275, ADH1, SFA1_1, MDH2HMG1, FAS2_1\_2, FAS2_2\_2, FAS2_3\_2, FAS2_4\_2, FAS2_5\_2, FAS2_6\_2, FAS2_7\_2, FAS2_8\_2, FAS1_1\_2, FAS1_2\_2, FAS1_3\_2, FAS1_4\_2, FAS1_5\_2, FAS1_6\_2, FAS1_7\_2, FAS1_8\_2, LYS9, ECM17LYS2_2, PRO2_1, U45\_, PRO3_3, HOM6_1, PGA3ARA1_2, r581, r572, r671, IDP2_1, r253, r833, ALD6, TYR1**Yeast 6.06**r_0714, r_0486, r_0470, r_0003--r_0169, r_0166, r_0179, r_0182, r_0186, r_0441, r_1010, r_2115r_0173, r_0177, r_0234, r_0659, r_0676, r_0690, r_0321, r_0939

During the manual curation process we observed that some of the flux constraints applied to enforce cofactor availability on the *S. cerevisiae* models ([Table 2](#t0010){ref-type="table"}) resulted in a lethal phenotype. The inability to produce some biomass components after applying the cofactor constraints was analysed in order to determine if the observed phenotype was a consequence of a faulty model structure or misleading assumptions about the reaction\'s feasibility. For *i*FF708 two constraints suffered from this issue: the inactivation of the squalene epoxidase (model ID: ERG1) and the inactivation of the cytosolic isocitrate dehydrogenase (model ID: IDP2_1). In the first case, ERG1 was inactivated because it could produce NADPH. However, this reaction is described to consume NADPH ([@bib35]), supported by the fact that the other models all had the correct stoichiometry. Therefore, we corrected the stoichiometry of ERG1 reaction in the model *i*FF708 and removed it from the list of reactions to be inactivated. Regarding the lethal phenotype associated with the inactivation of the cytosolic isocitrate dehydrogenase in *i*FF708, the reason for this behaviour was traced back to the lack of mitochondrial transporters for 2-oxoglutarate. Using the available knowledge about *S. cerevisiae* metabolism, we added two transporters for 2-oxoglutarate to *i*FF708: citrate/2-oxoglutarate antiporter (*YHM2*) and malate/2-oxoglutarate antiporter (*ODC1, ODC2*) ([@bib12], [@bib55]).

In the case of *i*MM904 a similar issue was encountered when the cytosolic isocitrate dehydrogenase (model ID: R_ICDHy) was inactivated. As before, the addition of the 2-oxoglutarate transporters solved this issue and restored normal growth. However, following the addition of these transporters there was an abnormal increase in biomass formation caused by an artificial cycle of proton export from the mitochondria, similar to the one observed for the original Yeast 6 and discussed in [Section 3.1](#s0040){ref-type="sec"}. It was solved by changing the reversibility of three mitochondrial transporters: aspartate:proton symporter (model ID: R_ASPt2m), oxaloacetate:proton symporter (model ID: R_OAAt2m) and mitochondrial dicarboxylate carrier for L-malate (model ID: R_MALtm) were allowed only to transport into the mitochondria. These changes restored normal growth levels.

Regarding Yeast 6, the list of reactions to be inactivated also included two candidates that were essential for growth: sterol dehydrogenase (model ID: r_0234) and prephenate dehydrogenase (model ID: r_0939). In both cases, these reactions were present in Yeast 6 as NADP^+^ dependent, but information from the literature pointed to NAD^+^ dependent versions ([@bib4], [@bib40]). Thus, the alternative NAD^+^ versions of both enzymes were introduced into Yeast 6, which solved the lethal phenotypes observed.

Using the GEMs containing the flux restrictions from [Table 2](#t0010){ref-type="table"} and the corrections described above, we simulated again the flux distributions using pFBA and analysed the differences between the curated models and the original ones ([Fig. 3](#f0015){ref-type="fig"}(A)). To serve as reference values we also included in [Fig. 3](#f0015){ref-type="fig"}(A) two sets of experimentally determined flux values obtained with ^13^C-Metabolic Flux Analysis of labelled glucose chemostats ([@bib23], [@bib28]). [Fig. 3](#f0015){ref-type="fig"}(A) shows that the curation process resulted in an increase in the oxidative PPP flux (GND) in all models, which was more dramatic in iMM904, iTO977 and Yeast 6. Furthermore, there were also other improvements in reactions related to NADPH/NADH metabolism. The complete set of central metabolic fluxes is shown in supplementary [Fig. S1](#s0070){ref-type="fn"} for each model under analysis.Fig. 3Comparison between the original and curated flux distributions for the models iFF708, iMM904, iTO977 and Yeast 6. A- Most relevant changes in the flux distributions of the curated models simulated with pFBA in comparison to two experimental flux data sets obtained with 13C-Metabolic Flux Analysis of labelled glucose chemostats ([@bib23], [@bib28]); B- comparison between the experimentally determined fluxes (*x*-axis) and pFBA simulation of each model (*y*-axis). For each graph it is shown: the linear regression equation, the correlation coefficient (R^2^), the Spearman correlation coefficient, the Pearson correlation coefficient and the sum of differences. The experimental fluxes used in the correlations were obtained by averaging both sets of data ([@bib23], [@bib28]). The flux values shown are normalized to a glucose uptake rate of 100 arbitrary units. Abbreviations: ALD- aldehyde dehydrogenase, GDH1- NADP^+^-dependent glutamate dehydrogenase, GDH2- NAD^+^-dependent glutamate dehydrogenase, GND- 6-phosphogluconate dehydrogenase, ICDHc- cytosolic NADP-specific isocitrate dehydrogenase, ICDHm- mitochondrial isocitrate dehydrogenase, OAAt- oxaloacetate transport from the cytosol to the mitochondria, PGI- phosphoglucose isomerase, TAL- Transaldolase, TKT1- transketolase (D-xylulose-5P + ribose-5P \<-\> sedoheptulose-7P+glyceraldehyde-3P), TKT2- transketolase (D-erythrose-4P+D-xylulose-5P \<-\>D-fructose-6P+glyceraldehyde-3P).Fig. 3

Focusing the analysis on *i*FF708 ([Fig. 3](#f0015){ref-type="fig"}(A)), there was an increase in the flux through the oxidative PPP to levels closer to the experimental fluxes. This increase was a consequence of an extra consumption of NADPH for anabolic purposes. Since many of the anabolic reactions present in the original *i*FF708 can consume either NADH or NADPH, when the NADH consuming partners were constrained ([Table 2](#t0010){ref-type="table"}) the cell had to synthesize essential biomass components using NADPH as an electron donor. As a consequence, the flux through the PPP had to compensate for the increased requirements for this cofactor. Another visible difference is the increased transport of oxaloacetate into to the mitochondria (OAAt), which can be explained by the inactivation of the cytosolic isocitrate dehydrogenase (ICDHc) and the addition of the mitochondrial 2-oxoglutarate transporters. These modifications shifted 2-oxoglutarate production from the cytosol to the mitochondria, resulting in an increase in the anaplerotic flux of oxaloacetate into the mitochondria.

Regarding *i*MM904, one of the most noticeable problems observed in the model comparison ([Fig. 2](#f0010){ref-type="fig"}) was the lack of flux in the oxidative PPP. As shown in [Fig. 3](#f0015){ref-type="fig"}(A), in the curated *i*MM904 the flux through the oxidative PPP (GND) increased dramatically in comparison to the original model and the simulated flux value is within the interval of values determined experimentally ([@bib23], [@bib28]). The modification that contributed the most to the improvement observed in the oxidative PPP was the deactivation of the cytosolic isocitrate dehydrogenase (ICDHc), which shifted NADPH production to the PPP. As a consequence of the increase in flux in the oxidative PPP, the fluxes in the non-oxidative PPP (TAL, TKT1 and TKT2) changed direction when compared to simulations of the original model and became consistent with the experimental flux data. There was also an improvement in the mitochondrial isocitrate dehydrogenase (ICDHm) as a consequence of the deactivation of the cytosolic isocitrate dehydrogenase in conjunction with the introduction of the 2-oxoglutarate transporters.

Similarly to *i*MM904, *i*TO977 also showed improvements in PPP and citric acid cycle. In this case, the reason for the zero flux through the PPP was solely the activity of the cytosolic isocitrate dehydrogenase (ICDHc), which was supplying all the NADPH required for growth. Furthermore, this issue was also responsible for the low flux through mitochondrial isocitrate dehydrogenase (ICDHm). Consequently, the cofactor constrains applied to the model solved both of these problems ([Fig. 3](#f0015){ref-type="fig"}(A)).

In the case of Yeast 6, the curated model showed improvements on several pathways, which included the PPP, transport of oxaloacetate and in the ammonium assimilation. Similarly to the other models, the increase in the oxidative part of the PPP (GND) is one of the most prominent differences in comparison to the original model simulation. Additionally, the non-oxidative reactions of the PPP (TAL, TKT1 and TKT2) changed direction in comparison to the original model and became consistent with experimental flux values. Another considerable difference between the original and curated models is the cofactor usage by the glutamate dehydrogenase reaction. After the curation process, the cofactor used in the glutamate dehydrogenase reaction changed from NADH (GDH2) to NADPH (GDH1), which increased the requirements for NADPH considerably. The preference of *S. cerevisiae* for the NADPH dependent glutamate dehydrogenase is consistent with the importance of this enzyme *in vivo* ([@bib3], [@bib16]). We also observed an improvement in the prediction of the flux of oxaloacetate into the mitochondria in the curated model (OAAt) and a decrease in the cytosolic aldehyde dehydrogenase (ALD), which was the source of NADPH in the simulations made for the original model.

In order to analyse quantitatively the improvements observed in the curated models, we plotted the simulated fluxes against the corresponding experimental values in [Fig. 3](#f0015){ref-type="fig"}(B) and analysed statistically the correlation between them. For the revised *i*FF708 model all the parameters analysed improved slightly with the exception of the Spearman coefficient. The modest improvements observed for the curated *i*FF708 are consistent with the fact this model had the best initial flux distribution. However, for the other three models the improvements are much more pronounced, and in all cases the correlation coefficients show that the curation process resulted in a much better prediction of metabolic fluxes in the central metabolism.

Given the non-uniqueness of the FBA/pFBA simulations, it is possible that the flux distributions computed with these methods suffer from variability even when the objective function is at its optimal value. Therefore, the flux changes analysed in this section could have been a consequence of flux variability and not related with the curation process undertaken. In order to test this, we performed Flux Variability Analysis ([@bib10], [@bib39]) for each flux shown in [Fig. 2](#f0010){ref-type="fig"}. The fluxes that showed more than 10% variation in comparison to the value obtained with pFBA are listed in supplementary [Table S5](#s0070){ref-type="fn"}. The analysis of the variable flux values showed that the changes observed between the original and curated models were a consequence of the constraints applied. A thorough analysis of the variable flux values is given in supplementary Text S1.

The genome-scale models modified in this study are provided in supplementary material in SBML format. Two versions of each model are supplied: one version includes general corrections of the problems we encountered in each model during the curation process and another version with all the cofactor constrains shown in [Table 2](#t0010){ref-type="table"}.

3.3. Additional flux inconsistencies {#s0050}
------------------------------------

After the manual curation process, some of the fluxes in the central carbon metabolism were still incorrectly simulated by pFBA. One of such cases was the absence of flux through the normal pathway for L-threonine production in the model *i*TO977 (THRS in supplementary [Fig. S1](#s0070){ref-type="fn"}). The absence of flux in this pathway was caused by the existence of an alternative route for L-threonine production using a threonine aldolase reaction that converts glycine and acetaldehyde to L-threonine in this model (model ID: GLY1). Although the threonine aldolase reaction is present in all models, only in *i*TO977 it can occur in the direction of L-threonine production. This reaction is reported in the literature as a possible source of glycine in *S. cerevisiae* ([@bib42], [@bib46])*,* but it has not been reported yet that it can also act as a source of L-threonine. In fact, *S. cerevisiae* becomes auxotrophic for L-threonine when threonine synthase is inactivated ([@bib33], [@bib41]), which suggests that the threonine aldolase cannot act as an L-threonine source in this organism.

In the model Yeast 6 we also detected an issue regarding the synthesis of acetyl-CoA in the cytosol. As shown in supplementary [Fig. S1](#s0070){ref-type="fn"}, no flux is predicted through acetyl-CoA *syn*thetase (ACS in supplementary [Fig. S1](#s0070){ref-type="fn"}), which seems strange given the essentiality of acetyl-CoA synthesis in the cytoplasm. Again, an erroneous reversibility was responsible for this problem: the cytosolic acetyl-CoA hydrolase (model ID: r_0110) was able to catalyse the reverse reaction, joining acetate and coenzyme A without an energy input. This enzyme is reported to be located in the mitochondria and there is no indication that it can catalyse the ligation of acetate and coenzyme A ([@bib19]).

3.4. Impact of reference flux distributions in the simulation of mutant phenotypes {#s0055}
----------------------------------------------------------------------------------

Among the simulation methods available to compute the phenotype of a mutant organism using GEMs, there is a group which assumes that the mutant cell will try to minimize the magnitude of its adaptation in comparison to the wild-type. Within this group of simulation methods there are several alternatives, such as MOMA ([@bib62]), lMOMA ([@bib5]), ROOM ([@bib63]) or MiMBL ([@bib8]), which differ in the metric used for minimising the distance between the wild-type and the mutant cell. These simulation algorithms require a reference distribution of fluxes to be used as an indication of the metabolic status in the wild-type organism and a few studies have indicated that the simulation results of MOMA and MiMBL are sensitive to the set of fluxes used as reference ([@bib8], [@bib62]).

Since the simulation methods mentioned above rely on a set of reference fluxes for their computations, their results might be affected by the inaccurate fluxes discussed in [Section 3.1](#s0040){ref-type="sec"}. To test how the improvements observed in the curated flux distributions ([Section 3.2](#s0045){ref-type="sec"}) would perform in comparison to the original ones, we used the model Yeast 6 and the lMOMA algorithm ([@bib5]) to compute the phenotype of strains obtained for the production of two organic acids, acetate and mevalonate.

In order to obtain strains with increased production *in silico* of acetate and mevalonate we used the evolutionary algorithm included in OptFlux to search for sets of optimal knock-outs. During the optimization process we used the curated flux distribution as a reference but the original reaction constraints were kept unchanged. Since some of the knock-outs implemented during the optimization process could alter the abundance of NADPH or NADH, the flux constraints derived from the curation process ([Table 2](#t0010){ref-type="table"}) might not be applicable to the mutant strains simulated.

[Table 3](#t0015){ref-type="table"} shows a selection of the strain designs obtained with OptFlux for the optimization of mevalonate and acetate production by using the improved flux distribution as a reference during the strain optimization process. One strain design for each case study is presented in [Table 3](#t0015){ref-type="table"}, with detailed information about the gene knock-outs necessary to achieve the corresponding production yields. The results shown for the original reference were obtained by simulating the same strain designs with the flux distribution for Yeast 6 show in [Fig. 2](#f0010){ref-type="fig"}.Table 3Impact of flux distributions in the performance of strain designs obtained with OptFlux for mevalonate and acetate production using lMOMA (the standard names of the deleted genes are shown in bold).Table 3**TargetInactivated reactionsProduct yield (g/g glucose)**Mevalonate***MTD1***: NAD^+^+5,10-methylene-THF -\> NADH +5,10-methenyl-THF\
***LSC1*** or ***LSC2*****:** ADP(m)+ HPO~4~^2-^(m)+ Succinyl-CoA(m) -\> CoA(m)+ Succinate(m)+ ATP(m)\
***GDH1*** and ***GDH3*****:** H^+^+ NH~4~+ NADPH +2-oxoglutarate -\> H~2~O +[L]{.smallcaps}-glutamate + NADP^+^Corrected reference: 0.056Original reference: 0.0075      Acetate***ZWF1*****:** D-glucose-6-phosphate + NADP^+^ -\> H^+^+ NADPH +6-phosphogluconolactone\
***IDP2*****:** NADP^+^+ Isocitrate -\> CO~2~+ NADPH +2-oxoglutarate\
***GDH2*****:** NAD^+^+ H~2~O +L-glutamate \<-\> H^+^+ NADH + NH~4~+2-oxoglutarate\
***AAT2*****:** L-aspartate +2-oxoglutarate \<-\>L-glutamate + OxaloacetateCorrected reference: 0.045Original reference: 0.0

As shown in [Table 3](#t0015){ref-type="table"}, the mevalonate producing mutant obtained in the optimization procedure required the inactivation of three different metabolic reactions (corresponding to four genes) to achieve a yield of 0.056 g mevalonate/g glucose. A detailed inspection of the changes in the flux distribution ([Fig. 4](#f0020){ref-type="fig"}) revealed that the deletion of the NADPH-dependent glutamate dehydrogenases (*GDH1* and *GDH3*) causes a surplus in the availability of NADPH. The deletion of the NAD^+^-dependent 5,10-methylenetetrahydrafolate dehydrogenase (*MTD1*) is necessary to avoid the transfer of electrons from NADPH to NAD^+^, forcing the excess of NADPH to be used elsewhere. With the inactivation of the succinyl-CoA synthetase (gene name - *LSC1,* ID in [Fig. 4](#f0020){ref-type="fig"} - SUCOAS) the citric acid cycle is broken and part of the flux is redirected to pyruvate decarboxylase (PDC), which originates an excess of acetyl-CoA that is re-assimilated using the enzymes from glyoxylate cycle. Furthermore, this deletion also causes an excess of acetyl-CoA in the mitochondria, which can be condensed into hydroxymethylglutaryl-CoA (HMGCoa) and transported to the cytosol. In that compartment, this metabolite can be converted to mevalonate while consuming NADPH, which alleviates the excess of this cofactor. In summary, two deletions are required to increase the amount of NADPH available in the cytosol, while the other increases the flux to hydroxymethylglutaryl-CoA (precursor of mevalonate). If the original reference flux distribution would be used in the phenotype simulation, the amount of mevalonate excreted by this mutant would be around seven times lower ([Table 3](#t0015){ref-type="table"}), which shows the impact of the reference distribution of fluxes in phenotype simulation. The differences observed in the mevalonate yield are a consequence of the dependence of the mevalonate production on an engineering strategy based on NADPH availability.Fig. 4Flux distributions simulated with lMOMA for the mevalonate mutant (A) and the acetate mutant (B) using the improved flux distribution as the reference. The wild-type flux values are shown in green, the mutant values are shown in red and the knock-outs are signalled by a red cross. The flux values shown are normalized to a glucose uptake rate of 100 arbitrary units. Reactions: ACONT- aconitase, ADE3- cytosolic C1-tetrahydrofolate synthase, AKGD- alpha-ketoglutarate dehydrogenase, ALD- aldehyde dehydrogenase, CSm- citrate synthase, FBA- fructose 1,6-bisphosphate aldolase, FUM- fumarase, GAPD- glyceraldehyde-3-phosphate dehydrogenase, GDH1/3- NADP^+^-dependent glutamate dehydrogenase, GDH2- NAD^+^-dependent glutamate dehydrogenase, GND- 6-phosphogluconate dehydrogenase, HEX- hexokinase, HMG1- HMG-CoA reductase, ICD- mitochondrial isocitrate dehydrogenase, ICL- isocitrate lyase, IDP2- cytosolic NADP-specific isocitrate dehydrogenase, MALS- malate synthase, MDH- mitochondrial malate dehydrogenase, ME- mitochondrial malic enzyme, MTD1- NAD-dependent 5,10-methylenetetrahydrafolate dehydrogenase, PDC- pyruvate decarboxylase, PDH- pyruvate dehydrogenase, PFK- phosphofructokinase, PGI- phosphoglucose isomerase, PGK- 3-phosphoglycerate kinase, PGMT- phosphoglucomutase, PP3- sum of the non-oxidative reactions of the pentose phosphate pathway producing glyceraldehyde-3-phosphate, PP6- sum of the non-oxidative reactions of the pentose phosphate pathway producing fructose-6-phosphate, PYC- pyruvate carboxylase, PYK- pyruvate kinase, SUCD- succinate dehydrogenase, SUCOAS- succinyl-CoA ligase, THRS- threonine synthase, TPI- triose phosphate isomerase; Metabolites: 13dPG- 1,3-diphosphoglycerate, 3PG- 3-phosphoglycerate, AcCoA- acetyl-CoA, Akg- 2-oxoglutarate, Cit- citrate, DHAP- dihydroxyacetone-phosphate, Fum- fumarate, G3P- glyceraldehyde-3-phosphate, Glx- glyoxylate, Icit- isocitrate, HMGCoa- 3-hydroxy-3-methylglutaryl-CoA, Mal - L-malate, Oaa- oxaloacetate, Succ- succinate, SucCoa- succinyl-CoA. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 4

Experimental evidence is available in the literature to support part of the strategy presented here for *in silico* mevalonate production. The inactivation of *GDH1* was implemented by [@bib47] to alter cofactor abundance in anaerobic conditions to decrease glycerol accumulation. Furthermore, [@bib500] also used the *GDH1* deletion to increase the abundance of NADPH and consequently boost the flux through the mevalonate pathway as part of a metabolic engineering strategy to increase α-santalene production. The production of cubebol also benefited from the increased NADPH pool resulting from *GDH1* deletion ([@bib2]). Given the experimental evidences supporting the *in silico* predictions, it seems that the improved reference flux distribution is much better to represent the metabolism of the wild-type *S. cerevisiae*, especially in areas related to NADPH production/consumption.

Regarding the acetate producing mutant, there is also a considerable difference in the acetate yield depending on which reference flux distribution is used ([Table 3](#t0015){ref-type="table"}). A quick analysis of the gene deletions required to induce acetate production revealed that, similarly to the mevalonate producing mutant, NADPH metabolism is also involved in this case. However, in this case the key to produce acetate *in silico* is forcing the cytosolic NADP^+^-dependent aldehyde dehydrogenase (gene name -- *ALD6,* ID in [Fig. 4](#f0020){ref-type="fig"} - ALD) to be the source of cytosolic NADPH ([Fig. 4](#f0020){ref-type="fig"}).

To reach the acetate producing phenotype, glucose-6-phosphate dehydrogenase (gene name -- *ZWF1,* ID in [Fig. 4](#f0020){ref-type="fig"} - GND) must be deleted so that the oxidative PPP becomes inactivated. Since this pathway is the main source of NADPH in the cytosol, the metabolic network has to adapt to the lack of this cofactor by activating other possible production sources. Furthermore, the list of required knock-outs also includes the cytosolic NADP-specific isocitrate dehydrogenase (*IDP2*), which can also be a possible source of NADPH for the cell. The final two deletions act on the other side of NADPH metabolism, i.e., on possible sinks of this cofactor. The deletion of the NADH-dependent glutamate dehydrogenase (*GDH2*) is necessary to "force" the use of the NADPH dependent enzyme (GDH1/GDH3) for ammonium assimilation. With the same goal, deleting the cytosolic aspartate aminotransferase (*AAT2*) also increases the flux through the NADPH dependent glutamate dehydrogenase. As shown in [Fig. 4](#f0020){ref-type="fig"}, all four deletions trigger rearrangements on the NADPH metabolism that culminate in an increased flux through the cytosolic NADP^+^-dependent aldehyde dehydrogenase (gene name -- *ALD6,* ID in [Fig. 4](#f0020){ref-type="fig"} - ALD). Since this reaction becomes the main source of NADPH in the cytosol, the extra flux results in acetate accumulation.

Experimental data regarding the inactivation of the glucose-6-phosphate dehydrogenase (*ZWF1*) in *S. cerevisiae* has shown that this knock-out can decrease the availability of cytosolic NADPH, resulting in reduced growth on glucose minimal medium ([@bib6]), methionine auxotrophy ([@bib64]) and increased sensitivity to oxidizing agents ([@bib48]). In the absence of the glucose-6-phosphate dehydrogenase it has been shown that the cytosolic NADP-specific isocitrate dehydrogenase (*IDP2*) can also fulfil the NADPH production role ([@bib44]). Furthermore, the overexpression of the cytosolic NADP^+^-dependent aldehyde dehydrogenase (*ALD6*) has been demonstrated to solve the methionine auxotrophy by increasing the availability of cytosolic NAPDH ([@bib24]). The compensation between the enzymes mentioned above, as the cytosolic NADPH source, supports the behaviour of the acetate producing mutant in [Table 3](#t0015){ref-type="table"} and indicates that the model is predicting accurately the NADPH metabolism when the curated flux distribution is used.

4. Conclusions {#s0060}
==============

In conclusion, we observed that the oldest GEM of *S. cerevisiae* (*i*FF708) showed the best prediction of central carbon fluxes. This fact might be explained by extra validation and curation steps performed during its construction ([@bib20]). *i*FF708 is still preferred by many authors in metabolic engineering projects over the more recent GEMs because of its better description of fluxes in the central metabolism ([@bib2], [@bib7], [@bib9], [@bib54]).

The results presented here, showed that the flux distributions of the newer GEMs could be significantly improved by imposing flux constraints on reactions involved in the metabolism of NADPH and NADH. The changes applied to cofactor metabolism had the most impact on central metabolic fluxes related to NADPH metabolism, especially in the oxidative PPP. The reactions involved in the production of NADH were not as affected by the imposed constraints because the simulations of the original models were quite good in this regard. The better predictions of NADH metabolism were most likely a consequence of the central role of this metabolite for ATP production in the oxidative phosphorylation.

Since the cofactor constraints proposed here revealed that similar flux distributions can be obtained with more recent models, it is now possible to take advantage of better compartmentalization, elementally balance reactions and increased genome coverage, without sacrificing the quality of fluxes in the central metabolism. This work also showed that the application of GEMs for strain simulation/design using algorithms that require a reference flux distribution should be preceded by a careful validation of the model predictions of the fluxes for the wild-type organism.

Appendix A. Supplementary material {#s0075}
==================================
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[^1]: Metabolic compartments refer to aqueous intracellular compartments, while the non-metabolic include the extracellular space and cellular membranes.
